Jazz Pharmaceuticals Plc Share Price (JAZZ.US)

$235.75..+6.20...(+2.70%)

https://www.google.com/finance/beta/quote/JAZZ:NASDAQ

Sliced again for *$235.2 all time high .

Still have large holding , plus in ISA which will not allow rebuy .

3rd Sell in a row now.

Average Price Target: ~$242.00 – $250.00

6th this year 2026 ( two buy backs )

UBS Upgrade: On May 19, 2026, UBS upgraded JAZZ to Buy from Neutral, significantly raising its price target to $307.

This shift reflects confidence in Ziihera, a gallbladder cancer treatment with an FDA regulatory deadline of August 25, 2026.

205.00...2.28 (1.12%) ...Bid: 202.10...Ask: 207.40...Spread: 5.30 (2.622%)

$ 212.41+0.15(+0.07%) Brokers platform .

Sliced for 210.6

https://stockstory.org/us/stocks/nasdaq/jazz

Saw this after they do not like the share .

"We’re skeptical of Jazz Pharmaceuticals. Its poor returns on capital indicate it barely generated any profits, a must for high-quality companies."

Close ..201.22...4.70 (2.39%) ...Bid: 194.53....Ask: 205.25...Spread: 10.72 (5.511%)

Market Cap: $12.10b

Sliced at $204 target had been $203.

All time high .

3 month low Friday 13th March $179 ( $ 10 below the 26th February buy back )

Todays news .

Jazz Pharmaceuticals Announces FDA Acceptance And Priority Review Of Supplemental Biologics License Application For Ziihera®

Now has its own page on this site .

Former posts on Prothena Ord (0Y3M)

Still have the 26 Jan 2022 ones transferred in to ISA ( 18 ) i Web charge 1.5% dealing charge .

Broker ( D ) less then 0.3% approx 5 times cheaper .

.................................................................................................................................................................................

Last post 26 Feb 2026

At 8pm $189.33..-7.50..(-3.81%)

Bought one of yesterdays sales back at a lower $189 the low just after $ 188.60 , although the spread is $0.78.

Might of got bottom which is very unusual.

The four Analysts yesterday Buy. 2 Overweight .Outperform all Boost Target.

.......................................................................................................................................................................................

Some older ones .

29/3/23 Letter from ( W ) "after review of asset policy no longer allowing purchases into some cannabis related stocks "This one of them" .

Only ones with them in ISA Transfer in January 2022 ( 2k )

10/6/21 Sold out in W also out in the ISA .